Efficacy and safety of initial five years of adjuvant endocrine therapy in postmenopausal hormone receptor-positive breast cancer: A systematic review and network meta-analysis.

被引：0
|
作者：
Liao, Hao
Zhong, Jianxin
Pei, Wendi
Bin, Shao
Liu, Xiao-Ran
Rugo, Hope S.
Li, Huiping
机构：
[1] Peking Univ, Canc Hosp, Beijing, Peoples R China
[2] Peking Univ Third Hosp, Beijing, Peoples R China
[3] Beijing Canc Hosp, Beijing, Peoples R China
[4] Peking Univ Canc Hosp & Inst, Beijing, Peoples R China
[5] Univ Calif San Francisco, Dept Med, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA
[6] Minist Educ, Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China
[7] Peking Univ Canc Hosp & Inst, Dept Breast Oncol, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
535
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Initial 5Years of Adjuvant Endocrine Therapy in Postmenopausal Hormone Receptor-Positive Breast Cancer: A Systematic Review and Network Meta-Analysis
    Liao, Hao
    Pei, Wendi
    Zhong, Jianxin
    Shao, Bin
    Liu, Xiaoran
    Liu, Yaxin
    Zhang, Jiayang
    Rugo, Hope S.
    Li, Huiping
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [2] Comparative efficacy and safety of extended adjuvant endocrine therapy for hormone receptor-positive early breast cancer: a Bayesian network meta-analysis
    He, Peng
    Li, Jing
    Chen, Minyan
    Huang, Meng
    Qiu, Yibin
    Cai, Qindong
    Lin, Yuxiang
    Wang, Chuan
    Fu, Fangmeng
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 203 (01) : 13 - 28
  • [3] Comparative efficacy and safety of extended adjuvant endocrine therapy for hormone receptor-positive early breast cancer: a Bayesian network meta-analysis
    Peng He
    Jing Li
    Minyan Chen
    Meng Huang
    Yibin Qiu
    Qindong Cai
    Yuxiang Lin
    Chuan Wang
    Fangmeng Fu
    Breast Cancer Research and Treatment, 2024, 203 : 13 - 28
  • [4] Adjuvant Endocrine Therapy of Perimenopausal and Recently Postmenopausal Women With Hormone Receptor-Positive Breast Cancer
    Pan, Kathy
    Chlebowski, Rowan T.
    CLINICAL BREAST CANCER, 2014, 14 (03) : 147 - 153
  • [5] Efficacy and safety of fulvestrant in postmenopausal patients with hormone receptor-positive advanced breast cancer: a systematic literature review and meta-analysis
    Wang, Jiayu
    Xu, Binghe
    Wang, Wenna
    Zhai, Xiaoyu
    Chen, Xuelian
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 171 (03) : 535 - 544
  • [6] Efficacy and safety of fulvestrant in postmenopausal patients with hormone receptor-positive advanced breast cancer: a systematic literature review and meta-analysis
    Jiayu Wang
    Binghe Xu
    Wenna Wang
    Xiaoyu Zhai
    Xuelian Chen
    Breast Cancer Research and Treatment, 2018, 171 : 535 - 544
  • [7] Optimal extension time after initial endocrine therapy for postmenopausal hormone receptor-positive early-stage breast cancer: a systematic review and meta-analysis
    Zhang Ying
    Liu Linxun
    Zhao kechang
    Wang Xiaowu
    Gengzhi Huazhen
    Ma Zhijun
    BMC Women's Health, 25 (1)
  • [8] Efficacy and acceptability of neoadjuvant endocrine therapy in patients with hormone receptor-positive breast cancer: A network meta-analysis
    Zhang, Tingting
    Feng, Fubin
    Yao, Yan
    Qi, Lingyu
    Tian, Jinhui
    Zhou, Chao
    Dong, Shengjie
    Wang, Xue
    Sun, Changgang
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (08) : 12393 - 12403
  • [9] Correction to: Efficacy and safety of fulvestrant in postmenopausal patients with hormone receptor-positive advanced breast cancer: a systematic literature review and meta-analysis
    Jiayu Wang
    Binghe Xu
    Wenna Wang
    Xiaoyu Zhai
    Xuelian Chen
    Breast Cancer Research and Treatment, 2019, 173 : 487 - 487
  • [10] Neoadjuvant chemotherapy combined with endocrine therapy for hormone receptor-positive breast cancer: A systematic review and meta-analysis
    Ma, Hong-Fang
    Shen, Jun
    Xu, Bin
    Shen, Jian-Guo
    MEDICINE, 2023, 102 (46)
12345